When Danish biotech companies reach a certain size, the growth is usually supplemented by an acquisition offer from a bigger firm, often from abroad. There's nothing wrong with this model, says Christian Elling, managing partner at Lundbeckfonden Emerge, even if he would prefer to see a more of them stay in Denmark for longer, growing domestically.
This is not to say that firms must go public in Denmark with a Danish-centered approach, if this isn't in the best interest of investors, reports Danish media Finans.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
"Real world" patient data documents the long-term effects of ALK vaccines
In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.
Y-mabs CEO has big ambitions: Wants to create the Tesla of biotech
CEO at Y-mabs Claus Møller sees the potential to create "the Tesla within biotechnology" in the Danish-American cancer company, as reported by Danish media Børsen.
Contact with consumers will secure continued growth in China, says Sonova
Hearing aid manufacturer Sonova says direct contact with consumers on the growing Chinese market will be the way forward to increase growth.
AGC's Japanese and Danish factories to produce German biotech firm's drug candidate
German 4teen4 has chosen AGC Biologics as contract developer for the clinical testing of its drug candidate, procizumab.
EMA begins rolling review of another Covid-19 vaccine
The European Medicines Agency will assess the potential vaccine being developed by Valneva as data trickles in.
Regulatory Science Specialist 
Application Manager (GxP Systems) 
Clinical Trial Manager 
Director, Team Lead, Trial Management, Hematology 
GxP QA Compliance Manager for Quality Assurance 
Join us! And start to impact healthcare through innovation 
Director Regulatory Affairs 
Regulatory documentation Specialist 
Senior Director, Global Regulatory Lead 
Area Sales Manager, Life Sciences, BU Øresund Region 
Chemist for process development 
Clinical Bioinformatician 
Nordic Field Sales Manager 
Medical Director, Translational Medicine 
Global Stakeholder Partnership Manager 
KLIFO is looking for a talented and committed eTMF Manager for our Glostrup Office